KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Preferred Dividend Payments: 2015-2018

Historic Preferred Dividend Payments for Neogenomics (NEO) over the last 4 years, with Dec 2018 value amounting to $5.6 million.

  • Neogenomics' Preferred Dividend Payments rose 198.28% to $2.8 million in Q2 2018 from the same period last year, while for Jun 2018 it was $7.4 million, marking a year-over-year decrease of 51.98%. This contributed to the annual value of $5.6 million for FY2018, which is 46.65% down from last year.
  • Neogenomics' Preferred Dividend Payments amounted to $5.6 million in FY2018, which was down 46.65% from $10.5 million recorded in FY2017.
  • In the past 5 years, Neogenomics' Preferred Dividend Payments registered a high of $18.0 million during FY2016, and its lowest value of $40,000 during FY2015.
  • Moreover, its 3-year median value for Preferred Dividend Payments was $10.5 million (2017), whereas its average is $11.4 million.
  • Its Preferred Dividend Payments has fluctuated over the past 5 years, first surged by 44,927.50% in 2016, then slumped by 46.65% in 2018.
  • Over the past 4 years, Neogenomics' Preferred Dividend Payments (Yearly) stood at $40,000 in 2015, then soared by 44,927.50% to $18.0 million in 2016, then tumbled by 41.44% to $10.5 million in 2017, then crashed by 46.65% to $5.6 million in 2018.